Join us for our first charity symposium which will consider the role of corporate culture in serious compliance failures
Join us as we delve into ethics, compliance, corporate culture, and serious mistakes. We will consider how serious ethical and compliance issues arise and the role of organisational culture within that.
Organisational culture can seem a fuzzy thing when compared to the written SOPs, policies, processes and training we have in place to ensure compliance. Nevertheless a ‘poor culture’ undoubtedly contributes significantly to serious compliance risk. What is it though? How do we know if business culture is broken and how do we fix it?
This event offers a unique opportunity to network with like-minded individuals, exchange ideas, and gain valuable knowledge in an informal atmosphere.
We have limited spaces at this event to 50, within a small auditorium, in order to ensure full audience participation in discussions with the expert faculty.
Don’t miss out on what we expect to be a thought-provoking event. Mark your calendars for December 6, 2023, follow the link to book your spot and join us at The Royal Society of Medicine, London.
We look forward to seeing you there!
Ethics, Compliance, Corporate Culture and the Avoidance of Cockup
Date: Wednesday, December 6, 2023
Time: 09:00 – 16:30 (GMT)
Location: 1 Wimpole Street, London, W1G 0AE
All proceeds from this event will be donated to…
Bucket List Wishes
Your speakers for the day and a bit about what they’ll be discussing
Dr Nick Broughton
Founding Partner, Ethos Ethics and Compliance
Will consider organisational culture, what it is and the evidence it contributes to major ethical failure and compliance risk.
Professor Raanan Gillon
Emeritus Professor of Medical Ethics, Imperial College London
What happens when personal ethical perspective conflicts with the direction an organisation is taking? Professor Gillon doesn’t provide a set of answers but he does offer a shareable way of coming to such answer.
Mr Alex Fell
Director of the PMCPA
Will reflect on major compliance errors in the past and their root causes. Looking beyond written process and training, what indicators are there that a company is at risk of major compliance failings and what practically can be done about it?
Ms Jill Pearcy
Director of Reputation, ABPI
Will look at the culture of the industry as a whole and consider what the current perception of it is. Is it worth trying to change that and if so how?
Ms Trishna Bharadia
Patient engagement expert, health advocate and speaker
Will propose that the patient must be central to corporate culture in pharma, and reflect on the evidence that the industry is currently failing in that regard. Which companies are getting it right and what are they doing?
Dr Henrietta Hughes
Patient Safety Commissioner for England
Will reflect on her experience amplifying the voice of patients and promoting patient safety. What systemic challenges to ethical behaviour are there in
large organisations and how can change be achieved?
Dr David Gillen
Chief Medical Officer, Norgine
Will chair a debate to consider what is a strong ethical culture and how can it be achieved in a business environment. Is an ethical and compliant culture necessarily a less profitable one?
Dr Vinay Patroe
Medical Director, Janssen UK
Will join the debate and provide a short personal reflection on what is important in an ethical culture and the practical mechanisms for delivering this.
Dr Simon Newton
General Manager, UK and Ireland, Jazz Pharma
Will join the debate and provide a short personal reflection on what is important in an ethical culture and the practical mechanisms for delivering this.
Dr Samin Saeed
Chief Medical Officer, PharmaReview Ltd
Will join the debate and provide a short personal reflection on what is important in an ethical culture and the practical mechanisms for delivering this.
Dr Philip Hammond
Retired doctor, broadcaster, journalist and comedian
Will round off the event with a broad perspective on the subject of organisational cockup, its root causes and how to lessen the risk of it, drawing on his experience inside and outside of healthcare and his knowledge of pharma.